Pathological examination revealed invasive ductal carcinoma measuring 1.8 cm, which was estrogen receptor (ER)-positive, progesterone receptor (PR)-positive, human epidermal growth factor receptor type 2 (HER2)-unknown and negative for lymph node involvement. The gene discussed is PGR; the disease is invasive ductal breast carcinoma.